Your browser doesn't support javascript.
loading
Recalling P446. P4501A1 (CYP1A1) opting for clinical application.
Hildebrandt, Alfred G; Schwarz, Dieter; Krusekopf, Solveigh; Kleeberg, Ullrich; Roots, Ivar.
Affiliation
  • Hildebrandt AG; Drachenfelsstr., Bonn, Germany. abhildebrandt@aol.com
Drug Metab Rev ; 39(2-3): 323-41, 2007.
Article in En | MEDLINE | ID: mdl-17786624
This review goes back to spectral studies [see Hildebrandt et al., 1968]. The findings of apparent absolute spectra of two interconvertible forms of microsomal mixed function oxidases are looked back on to recall whether their impact sustained scrutiny or are rather remembered as of sentimental value only. The second part summarizes studies on the clinical relevance of CYP1A1 with special reference to our investigations. The impact of genetic variability of CYP1A1 on cancer susceptibility, differential effects of polyphenols and hyperforin on toxification and detoxification pathways of benzo[a]pyrene, and differential metabolite patterns of 17 beta-estradiol, estrone, and eicosapentaenoic acid are presented.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Cytochrome P-450 CYP1A1 Limits: Animals / Humans Language: En Journal: Drug Metab Rev Year: 2007 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pharmacology, Clinical / Cytochrome P-450 CYP1A1 Limits: Animals / Humans Language: En Journal: Drug Metab Rev Year: 2007 Document type: Article Affiliation country: Germany Country of publication: United kingdom